Answers are grounded in this paper and cite their sources.
Combined, our data reveal high gene and drug specificity in the contributions of rare variants. We provide a proof-of-concept on how this information can be utilized to pinpoint genes for which sequencing-based genotyping can add important information to predict drug response, which provides useful information for the design of clinical trials in drug development and the personalization of pharmacological treatment.
No takes yet. Share an insight, caveat, or question.
Ingelman‐Sundberg et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: